Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library
- 1 February 2011
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 81 (3), 402-411
- https://doi.org/10.1016/j.bcp.2010.11.005
Abstract
No abstract availableKeywords
Funding Information
- Swedish Research Council
- Swedish Society for Medical Research
- Medical Faculty of Göteborg
- The Swedish government under the ALF-agreement
- King Gustaf the Vth 80-year foundation
- The IngaBritt and Arne Lundberg Research Foundation
This publication has 49 references indexed in Scilit:
- Therapeutic anti-inflammatory potential of formyl-peptide receptor agonistsPharmacology & Therapeutics, 2010
- The FPR2-induced rise in cytosolic calcium in human neutrophils relies on an emptying of intracellular calcium stores and is inhibited by a gelsolin-derived PIP2-binding peptideBMC Cell Biology, 2010
- Circulating mitochondrial DAMPs cause inflammatory responses to injuryNature, 2010
- Identification of Novel Small-Molecule Agonists for Human Formyl Peptide Receptors and Pharmacophore Models of Their RecognitionMolecular Pharmacology, 2009
- Exploiting the Annexin A1 pathway for the development of novel anti‐inflammatory therapeuticsBritish Journal of Pharmacology, 2009
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) FamilyPharmacological Reviews, 2009
- Duplex high‐throughput flow cytometry screen identifies two novel formylpeptide receptor family probesCytometry Part A, 2008
- Anti-Inflammatory and Proresolving Lipid MediatorsAnnual review of pathology, 2008
- Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophilsClinical Rheumatology, 2006
- Newcastle disease virus neuraminidase primes neutrophils for stimulation by galectin-3 and formyl-Met-Leu-PheExperimental Cell Research, 2004